Lisdexamfetamine Dimesylate Capsules Solicitation

The Defense Logistics Agency (DLA) Troop Support is seeking proposals for Lisdexamfetamine Dimesylate capsules to serve as a national supply source for the Department of Defense (DoD), Department of Veterans Affairs (VA), Bureau of Prisons (BoP), and Indian Health Service (IHS). This procurement, under solicitation SPE2D2-26-R-0004, will establish a requirements-type contract featuring a one-year base period and four one-year options. The selected contractor will supply pharmaceutical products to DLA and VA Pharmaceutical Prime Vendor (PPV) contractors. All fourteen line items must be FDA-approved with a Therapeutic Equivalence (TE) Code of "A." Proposals are due via the DLA Internet Bid Board System (DIBBS) by July 2, 2026. The 69-page solicitation outlines technical requirements, pricing schedules, and compliance standards, including Current Good Manufacturing Practice (cGMP) and specific bar-code labeling. Proposals must be submitted through the DLA Internet Bid Board System (DIBBS). Evaluation is based on technical requirements and past performance, both of which must be rated acceptable. DLA Troop Support is procuring Lisdexamfetamine Dimesylate capsules for DoD, VA, BoP, and IHS activities through a requirements-type contract with a one-year base and four option years.